Ancitabine hydrochloride

  • CAT Number: I000151
  • CAS Number: 10212-25-6
  • Molecular Formula: C9H12ClN3O4
  • Molecular Weight: 261.66
  • Purity: ≥95%
Inquiry Now

Ancitabine hydrochloride(Cat No.:I000151), also known as 1-beta-D-arabinofuranosylcytosine hydrochloride or cytarabine hydrochloride, is an important antileukemia drug. It belongs to the class of nucleoside analogs and is commonly used in the treatment of acute myeloid leukemia (AML) and other hematological malignancies. Ancitabine is converted into its active form inside the cells, where it inhibits DNA synthesis and induces cell death in rapidly dividing cancer cells.

Catalog Number I000151
CAS Number 10212-25-6
Molecular Formula

C9H12ClN3O4

Purity 95%
Solubility 10 mM in DMSO
Storage 2-8°C
IUPAC Name (2R,4R,5R,6S)-4-(hydroxymethyl)-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-5-ol;hydrochloride
InChI InChI=1S/C9H11N3O4.ClH/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8;/h1-2,4,6-8,10,13-14H,3H2;1H/t4-,6-,7+,8-;/m1./s1
InChIKey KZOWNALBTMILAP-JBMRGDGGSA-N
SMILES C1=CN2C3C(C(C(O3)CO)O)OC2=NC1=N.Cl
Reference

<p style=/line-height:25px/>
<br>[1]. Z Rao, et al. Study on the Synthesis of Cytarabine Hydrochloride and its Intermediate Ancitabine Hydrochloride. Fine Chemical Intermediates, 2013

</p>

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!